Healthy volunteers help test new Drug's safety
NCT ID NCT06279533
First seen Nov 25, 2025 · Last updated May 13, 2026 · Updated 23 times
Summary
This study tested the safety and how the body handles a new drug called LV232 in 49 healthy Chinese volunteers. Participants took multiple doses of the drug, and researchers measured how it moved through the body and checked for side effects. This is an early-stage study with no direct treatment benefit, aimed at gathering important safety information.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Xuhui Central Hospital
Shanghai, China
Conditions
Explore the condition pages connected to this study.